Bsivo enters Samsung Medical Center after Severance and Seoul National University Hospital
‘Besivo Tab,’ an Ildong Pharmaceutical’s new chronic hepatitis B treatment, landed in Samsung Medical Center.
‘Besivo’ is increasing a chance to enlarge its market by entering major general hospitals from Severance Hospital, Seoul National University Hospital to Samsung Medical Center.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.